TCL Archive Drug pricing: Amgen’s “bundling” violates antitrust laws, J&J claims in suit. October 14, 2005
TCL Archive Blochs Plan To Fund National Network Of “Cancer Survivor Parks” In Every City August 3, 1990
TCL Archive Phase III Trial In Recurrent Disease Shows Lower Risk of Progression or Death by 34% June 28, 2013
TCL Archive International Cancer Program Enthusiasm A Spinoff From U.S. Program, XIIth Congress Demonstrates October 20, 1978
TCL Archive Six-Year Follow Up Of Phase III Sprycel Trial Demonstrates 71 Percent Overall Survival July 27, 2012
